By proceeding, you agree to our Terms of Use and Privacy Policy.
Welcome to the 3rd Tumor Myeloid-Directed Therapies SummitThe role of the myeloid compartment in tumor resistance is becoming clear. As the landscape of targets continues to grow, the potential to target and manipulate myeloid cells to relieve immunosuppression has received increasing focus, due to its ability to relieve immunosuppression in the tumor microenvironment. The 3rd Tumor Myeloid-Directed Therapies Summit captures this potential by uniting the industry leaders pioneering these myeloid activating therapies to share clinical progress while reviewing novel targets to activate macrophages, monocytes, dendritic cells and more. Collaborate and learn from myeloid experts across industry and academia over 3 in-depth days of content, as they address the key bottlenecks limiting the efficacy and safety of these exciting treatments, including in vivo models, biomarkers of response, combination rationale, and myeloid biology to accelerate myeloid directed therapies.
Discover the latest developments and advancements in myeloid therapy.
Gain exclusive access to insights and perspectives on recognizing the clinical impact of myeloid-targeted therapies to benchmark efficacy & safety.
Get involved in interactive sessions and discussions to harness the power of combination therapies, cell-based & direct cell-targeting approaches and more.
Learn from myeloid experts across the industry as they address the key bottlenecks limiting the efficacy and safety of myeloid-directed therapies.
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
Mission Bio is a company of passionate people dedicated to solving complex biological problems with precision engineering, innovative biochemistry, and supported bioinformatics.
Founded in 1999, genOway is a global biotechnology company dedicated to the development and commercialization of unique, innovative genetically modified mouse, rat and cell line models for fundamental, preclinical and clinical research.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.